Effects of Panax Notoginseng (Chinese Ginseng) and Acute Exercise on Postprandial Glycemia in Non-diabetic Adults

The purpose of this study is to determine whether Panax Notoginseng (PNG) taken for 3 days and one 30-min cycling exercise can reduce postprandial hyperglycemia after ingesting a 75-mg oral glucose solution (OGTT) in untrained non-diabetic men, age 20-45 years. We randomly assigned 52 men to: 1) gin...

Full description

Saved in:
Bibliographic Details
Published inJournal of complementary & integrative medicine Vol. 8; no. 1
Main Authors Liang, Michael T.C., Lau, W.Y. Jamie, Sokmen, Bulent, Spalding, Thomas W., Chuang, William J.
Format Journal Article
LanguageEnglish
Published Germany De Gruyter 04.01.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study is to determine whether Panax Notoginseng (PNG) taken for 3 days and one 30-min cycling exercise can reduce postprandial hyperglycemia after ingesting a 75-mg oral glucose solution (OGTT) in untrained non-diabetic men, age 20-45 years. We randomly assigned 52 men to: 1) ginseng (G) + exercise (G+Ex, n=14), 2) ginseng (G, n=13), 3) placebo (C) + exercise (C+Ex, n=12), and 4) placebo control groups (C, n=13). The G and C groups took a daily 3g dose of PNG and cornstarch-placebo supplement for 3 days, respectively. The exercise groups also performed a 30-min cycling exercise on day 3 prior to OGTT. The daily 3g-dose of PNG supplementation significantly lowered postprandial plasma glucose (PG) concentration at 30 min post-OGTT in the G group, compared with C (mean Δ±SE: G vs. C = 26.3±11 mg/dl, p<0.05) and PG area under the curve (PG-AUC0-90) in the G and G+Ex groups, relative to the C (G vs. C = 96.5±42 and G+Ex vs. C = 85.2±41 mg/dl, both p<0.05). We conclude that a daily 3g-dose of PNG taken for 3 days, not one acute bout of 30-min cycling exercise at 60% VO2max, lowered postprandial glycemia at 30-min post-OGTT and PG-AUC 0-90 min in non-diabetic men, age 20-45 years.
Bibliography:ark:/67375/QT4-ZVSH5CT8-8
istex:BD90604C074D1364711D76F00BBA2C6A36B51BDF
1553-3840.1402.pdf
ArticleID:1553-3840.1402
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:1553-3840
1553-3840
DOI:10.2202/1553-3840.1402